The US and the EU announced a mutual agreement to recognize one another’s good manufacturing practices in pharmaceutical facilities, a step that is expected to reduce costs and enable regulators to devote more resources to other areas of the world where the supply chain might face greater risk. The move will “help ensure that American patients have access to safe, effective, and high-quality drugs," said Dara Corrigan, FDA's associate commissioner for global regulatory policy.
On Tuesday, the Journal of the American Medical Association released results from a study on adverse drug events. The study examined nearly 42,600 cases from the National Electronic Injury Surveillance System — Cooperative Adverse Drug Event Surveillance project and found, in part, that the rate of ER visits of adults aged 65 years and older was three times that of those 65 and younger (9.7 visits per 1,000 individuals compared with 3.1, respectively.) Dig into more of the highlights in this Pharmalot story from Ed Silverman. According to the CDC, 11.9 percent of ER visits result in hospital admissions. It’s certainly not a brand new story, but it does highlight the opportunity for pharmacists to better engage with physicians and patients as a valuable part of the care team.